These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. Wallaschofski H, Kuwert T, Lohmann T. Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319 [Abstract] [Full Text] [Related]
6. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays. Zöphel K, Roggenbuck D, von Landenberg P, Wunderlich G, Grüning T, Kotzerke J, Lackner KJ, Rees Smith B. Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651 [Abstract] [Full Text] [Related]
7. Comparison of a solid phase human- versus porcine- thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Hermsen D, Liu C, Domberg J, Graeber C, Feldkamp J, Duan Y, Xu K, Liu C, Mao X, Scherbaum WA, Schott M. Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S59-63. PubMed ID: 18777457 [Abstract] [Full Text] [Related]
9. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial. Schott M, Hermsen D, Broecker-Preuss M, Casati M, Mas JC, Eckstein A, Gassner D, Golla R, Graeber C, van Helden J, Inomata K, Jarausch J, Kratzsch J, Miyazaki N, Moreno MA, Murakami T, Roth HJ, Stock W, Noh JY, Scherbaum WA, Mann K. Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704 [Abstract] [Full Text] [Related]
10. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease. Hirooka Y, Li C, Takagi J, Gotoh M, Habu S, Yasaka-Nomura T, Ishihara R, Nakasone Y, Nakamura R, Morikawa R, Otake K, Nogimori T, Ishizuki Y. Int J Clin Pharmacol Res; 2004 Oct; 24(4):111-6. PubMed ID: 15754915 [Abstract] [Full Text] [Related]
11. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Meller J, Jauho A, Hüfner M, Gratz S, Becker W. Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852 [Abstract] [Full Text] [Related]
12. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Takasu N, Kamijo K, Sato Y, Yoshimura H, Nagata A, Ochi Y. Clin Exp Pharmacol Physiol; 2004 Dec; 31(5-6):314-9. PubMed ID: 15191404 [Abstract] [Full Text] [Related]
13. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R. Horm Metab Res; 2001 Aug; 33(8):504-7. PubMed ID: 11544566 [Abstract] [Full Text] [Related]
16. [TSH anti-receptor antibodies in Graves' disease]. Sérgio MR, Godinho C, Guerra L, Agapito A, Fonseca F, Costa C. Acta Med Port; 1996 Aug; 9(7-9):229-31. PubMed ID: 9005701 [Abstract] [Full Text] [Related]
17. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies. Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A. Acta Med Austriaca; 1996 Aug; 23(1-2):52-6. PubMed ID: 8767515 [Abstract] [Full Text] [Related]